The Interaction of Insulin and Pituitary Hormone Syndromes.


Journal

Frontiers in endocrinology
ISSN: 1664-2392
Titre abrégé: Front Endocrinol (Lausanne)
Pays: Switzerland
ID NLM: 101555782

Informations de publication

Date de publication:
2021
Historique:
received: 09 11 2020
accepted: 06 04 2021
entrez: 17 5 2021
pubmed: 18 5 2021
medline: 18 12 2021
Statut: epublish

Résumé

Pituitary hormone axes modulate glucose metabolism and exert direct or indirect effects on insulin secretion and function. Cortisol and growth hormone are potent insulin-antagonistic hormones. Therefore impaired glucose tolerance, elevated fasting glucose concentrations and diabetes mellitus are frequent in Cushing's disease and acromegaly. Also prolactinomas, growth hormone (GH) deficiency, hypogonadism and hypothyroidism might be associated with impaired glucose homeostasis but usually to a lesser extent. Therefore glucose metabolism needs to be closely monitored and treated in patients with pituitary adenomas. Correction of the pituitary dysfunction is frequently followed by improvement of glucose homeostasis.

Identifiants

pubmed: 33995272
doi: 10.3389/fendo.2021.626427
pmc: PMC8113952
doi:

Substances chimiques

Blood Glucose 0
Insulin 0
Pituitary Hormones 0

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

626427

Informations de copyright

Copyright © 2021 Schernthaner-Reiter, Wolf, Vila and Luger.

Déclaration de conflit d'intérêts

The authors declare the following conflicts of interest: MS-R has received honoraria for presentations from HRA Pharma; GV has received lecture and/or consulting fees from Ipsen, Pfizer, Novo Nordisk, Recordati, Takeda and HRA Pharma, and is Research Investigator in studies sponsored by Novartis, Recordati, Corcept, Chiasma and Takeda; AL has received honoraria lecture and/or consulting fees from Ionis, Ipsen, Merck, Novartis, Pfizer, Sandoz. The remaining author declares that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Références

Cells. 2021 Jan 07;10(1):
pubmed: 33430527
Exp Clin Endocrinol. 1990 Aug;95(3):339-43
pubmed: 2245822
Eur J Endocrinol. 2011 Jun;164(6):877-84
pubmed: 21464140
Neuroendocrinology. 2013;98(4):299-310
pubmed: 24355865
Endocr Rev. 2013 Jun;34(3):309-38
pubmed: 23460719
Eur J Endocrinol. 2013 Feb 15;168(3):297-305
pubmed: 23211573
Horm Metab Res. 2019 Jan;51(1):62-68
pubmed: 30522146
J Clin Endocrinol Metab. 2013 Jan;98(1):E51-9
pubmed: 23162101
Endocr Relat Cancer. 2017 Oct;24(10):505-518
pubmed: 28733467
J Endocrinol Invest. 2016 Feb;39(2):235-55
pubmed: 26718207
Pituitary. 2011 Sep;14(3):231-5
pubmed: 21161601
J Clin Endocrinol Metab. 2013 Aug;98(8):3446-53
pubmed: 23733372
Diabetes Care. 2007 Feb;30(2):234-8
pubmed: 17259487
J Clin Endocrinol Metab. 1996 Feb;81(2):555-64
pubmed: 8636267
Eur J Endocrinol. 2012 Sep;167(3):311-26
pubmed: 22728347
Endocrine. 2016 Oct;54(1):1-2
pubmed: 27388591
J Clin Endocrinol Metab. 2003 Dec;88(12):5808-13
pubmed: 14671173
Basic Clin Pharmacol Toxicol. 2015 Mar;116(3):251-6
pubmed: 25123447
Eur J Endocrinol. 2013 Jul;169(1):127-32
pubmed: 23828957
Eur J Endocrinol. 2011 Sep;165(3):383-92
pubmed: 21715416
Endocr Rev. 2017 Jun 1;38(3):189-219
pubmed: 28368467
Endocr Pract. 2000 Nov-Dec;6(6):450-2
pubmed: 11155217
J Clin Endocrinol Metab. 2018 Jun 1;103(6):2369-2375
pubmed: 29618021
J Clin Endocrinol Metab. 2003 Apr;88(4):1554-8
pubmed: 12679438
Eur J Endocrinol. 2007 Aug;157 Suppl 1:S51-6
pubmed: 17785698
J Clin Endocrinol Metab. 2018 Mar 23;:
pubmed: 29590371
Diabetologia. 1985 Mar;28(3):138-42
pubmed: 3888755
J Endocrinol. 2014 Jan 27;220(3):R37-55
pubmed: 24353306
Ann Saudi Med. 2012 Sep-Oct;32(5):455-61
pubmed: 22871612
J Clin Endocrinol Metab. 2019 Jul 1;104(7):2892-2902
pubmed: 30869797
Endocrinol Diabetes Metab Case Rep. 2017 Feb 23;2017:
pubmed: 28458895
Diabetes. 2019 Feb;68(2):291-304
pubmed: 30487265
Clin Endocrinol (Oxf). 2011 Sep;75(3):354-60
pubmed: 21521323
J Clin Endocrinol Metab. 2010 Feb;95(2):592-600
pubmed: 20061432
Ther Adv Endocrinol Metab. 2020 May 13;11:2042018820917869
pubmed: 32489580
Endocrine. 2016 Jul;53(1):210-9
pubmed: 26906713
J Formos Med Assoc. 2007 Sep;106(9):788-91
pubmed: 17908670
Endocr Pract. 2013 Mar-Apr;19(2):252-8
pubmed: 23543030
Endocrinology. 2006 Oct;147(10):4638-45
pubmed: 16809445
Arch Endocrinol Metab. 2019 Nov-Dec;63(6):582-591
pubmed: 31939483
Metabolism. 2006 Aug;55(8):1135-40
pubmed: 16839852
Exp Clin Endocrinol Diabetes. 2007 Feb;115(2):146-50
pubmed: 17318778
Acta Med Austriaca. 2000;27(1):27-31
pubmed: 10812460
BMC Med. 2016 Sep 30;14(1):150
pubmed: 27686165
J Sex Med. 2011 Jan;8(1):272-83
pubmed: 20807333
Eur J Endocrinol. 2015 Oct;173(4):M133-57
pubmed: 26060052
Nat Rev Endocrinol. 2013 Aug;9(8):479-93
pubmed: 23797822
Endocr Rev. 2009 Apr;30(2):152-77
pubmed: 19240267
Clin Investig. 1993 May;71(5):372-8
pubmed: 8508007
J Clin Endocrinol Metab. 2017 May 1;102(5):1451-1453
pubmed: 28323955
Eur J Endocrinol. 2007 Oct;157(4):399-409
pubmed: 17893253
Clin Endocrinol (Oxf). 1998 May;48(5):547-53
pubmed: 9666865
Eur J Endocrinol. 2011 Apr;164(4):467-73
pubmed: 21285083
Front Endocrinol (Lausanne). 2019 Jul 30;10:509
pubmed: 31417493
J Clin Endocrinol Metab. 2012 Jun;97(6):2039-49
pubmed: 22466348
Clin Endocrinol (Oxf). 1994 Apr;40(4):479-84
pubmed: 8187313
J Clin Endocrinol Metab. 2003 Jun;88(6):2404-11
pubmed: 12788835
J Clin Endocrinol Metab. 2020 Apr 1;105(4):
pubmed: 31606735
Endocrinology. 2007 Dec;148(12):5977-83
pubmed: 17872372
J Clin Endocrinol Metab. 2015 Aug;100(8):2849-52
pubmed: 26086329
Postgrad Med J. 1996 Nov;72(853):682-3
pubmed: 8944212
Pituitary. 2014 Feb;17(1):81-9
pubmed: 23446424
Endocrine. 2019 Apr;64(1):157-168
pubmed: 30467627
Front Pharmacol. 2018 Jul 18;9:771
pubmed: 30072896
J Clin Endocrinol Metab. 2003 Jun;88(6):2527-33
pubmed: 12788849
Clin Endocrinol (Oxf). 2019 Dec;91(6):776-785
pubmed: 31465533
Eur J Clin Invest. 2000 Sep;30(9):771-8
pubmed: 10998076
N Engl J Med. 2012 Mar 8;366(10):914-24
pubmed: 22397653
Diabetologia. 2004 Jul;47(7):1175-1187
pubmed: 15252707
Clin Chem Lab Med. 2005;43(7):715-20
pubmed: 16207130
Endocrinology. 2017 Jan 1;158(1):56-68
pubmed: 27805870
Eur J Endocrinol. 2016 Sep;175(3):181-90
pubmed: 27280374
Clin Endocrinol (Oxf). 2014 Mar;80(3):403-10
pubmed: 23889360

Auteurs

Marie Helene Schernthaner-Reiter (MH)

Clinical Division of Endocrinology and Metabolism, Department of Medicine III, Medical University of Vienna, Vienna, Austria.

Peter Wolf (P)

Clinical Division of Endocrinology and Metabolism, Department of Medicine III, Medical University of Vienna, Vienna, Austria.

Greisa Vila (G)

Clinical Division of Endocrinology and Metabolism, Department of Medicine III, Medical University of Vienna, Vienna, Austria.

Anton Luger (A)

Clinical Division of Endocrinology and Metabolism, Department of Medicine III, Medical University of Vienna, Vienna, Austria.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH